BrainStorm's NurOwnA Demonstrates a Statistically Significant Effect in ALS Patients Phase 2a Results and New Analyses Presented at American Academy of Neurology /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwnA in amyotrophic lateral sclerosis at a poster session today at the American Academy of Neurology annual meeting, taking place in Among the new results is a piecewise linear regression analysis of all subjects who received intrathecal administration in the phase 2a study and the prior phase 1/2 study.
http://ift.tt/1aO0jae
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
The Raw Stem Cell News Feed
The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Subscribe to:
Post Comments (Atom)
Popular Stem Cell Roundup Posts
-
... president Enrico Garaci , who has served since 2001, has been attacked over his aversion to embryonic stem cell research and reluctance ...
-
... which an excellent scientific environment exists. Experience in the field of vascular neuroscience and/or stem cell research is helpful ...
-
... UC San Diego, there is a representative for each institute, because those are the people who know about stem cell research," said U...
-
... to avoid the appearance of conflict of interest. California has transformed into a powerhouse player in stem cell research, but the taxp...
-
Elijah Talley, 11, was diagnosed with stage 4 neuroblastoma at the age of 4. He has spent a majority of the last few years in the hospital r...
-
... voters approved Proposition 71 in 2004, authorizing the state to issue $3 billion in bonds to support stem cell research in California (...
-
Frank Farmer named to the Board Of Directors of World Stem Cell Institute, Inc. a 501 non-profit corporation involved in Stem Cell research,...
-
Patrys Limited , a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in mu...
-
Considerable advances have taken place since the initial isolation and characterization of human embryonic stem cells; however, significant ...
-
... Tools in Genetic Engineering 8. Microbial Genetics 9. Plant Genetic Engineering 10. Genetic Engineering & Stem Cell Research 11. Clo...
No comments:
Post a Comment